Works matching DE "GLUCAGON-like peptide 1"

Results: 3070

Management of Acquired Hypothalamic Obesity After Childhood-Onset Craniopharyngioma—A Narrative Review.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1016, doi. 10.3390/biomedicines13051016

By:

Müller, Hermann L.

Publication type:

Article

A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db / db Mice via PPAR Signaling Pathway.

Published in:

Nutrients, 2025, v. 17, n. 10, p. 1693, doi. 10.3390/nu17101693

By:

Han, Binsong;
Ye, Yuhui;
Zhang, Cunzheng;
Zhang, Lina;
Zhou, Peng

Publication type:

Article

Beneficial effects of liraglutide on peripheral blood vessels.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2022, v. 79, n. 2, p. 168, doi. 10.2298/VSP200423089Z

By:

Xueyang Zhang;
Yongbo Wang;
Simengge Yang;
Junwei Zong;
Xuejiao Wang;
Ran Bai

Publication type:

Article

Short term effects of experimental gastric outlet obstruction and truncal vagotomy on gut hormones.

Published in:

Biotechnic & Histochemistry, 2022, v. 97, n. 2, p. 90, doi. 10.1080/10520295.2021.1896780

By:

Sagkan Ozturk, Aliye;
Aydin, Mehmet;
Bozkurt, Yesim Akaydın;
Kuçukgul, Altug;
Ozturk, Atakan

Publication type:

Article

Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.

Published in:

Osteoporosis International, 2016, v. 27, n. 6, p. 1931, doi. 10.1007/s00198-015-3454-x

By:

Epstein, S.;
Defeudis, G.;
Manfrini, S.;
Napoli, N.;
Pozzilli, P.

Publication type:

Article

Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 209, doi. 10.1007/s00198-014-2845-8

By:

Mieczkowska, A.;
Mansur, S.;
Bouvard, B.;
Flatt, P.;
Thorens, B.;
Irwin, N.;
Chappard, D.;
Mabilleau, G.

Publication type:

Article

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 127, doi. 10.1007/s00228-023-03586-1

By:

Zachou, Maria;
Flevari, Pagona;
Nasiri-Ansari, Narjes;
Varytimiadis, Constantinos;
Kalaitzakis, Evangelos;
Kassi, Eva;
Androutsakos, Theodoros

Publication type:

Article

Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 793, doi. 10.1007/s00228-021-03249-z

By:

Guan, Ziwan;
Du, Yue;
Li, Rui;
Zhang, Shufang;
Xu, Yuedong;
Zhang, Xiaoqian;
Zhang, Fan;
Yin, Ying;
Wu, Kunrong;
Li, Xiaoli;
Li, Yan

Publication type:

Article

Exendin-4 improves cerebral ischemia by relaxing microvessels, rapidly increasing cerebral blood flow after reperfusion.

Published in:

Basic Research in Cardiology, 2025, v. 120, n. 2, p. 423, doi. 10.1007/s00395-025-01096-y

By:

Chen, Yujie;
Wang, Lei;
Zhou, Yutong;
Wang, Yuguang;
Qin, Wei;
Wang, Mingxiao;
Liu, Bo;
Tian, Qian;
Xu, Huisen;
Shen, Hui;
Zheng, Chen

Publication type:

Article

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.

Published in:

Basic Research in Cardiology, 2016, v. 111, n. 1, p. 1, doi. 10.1007/s00395-015-0518-1

By:

Tate, Mitchel;
Robinson, Emma;
Green, Brian;
McDermott, Barbara;
Grieve, David

Publication type:

Article

Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism.

Published in:

Basic Research in Cardiology, 2014, v. 109, n. 5, p. 1, doi. 10.1007/s00395-014-0426-9

By:

Goodwill, Adam;
Tune, Johnathan;
Noblet, Jillian;
Conteh, Abass;
Sassoon, Daniel;
Casalini, Eli;
Mather, Kieren

Publication type:

Article

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Published in:

Basic Research in Cardiology, 2013, v. 108, n. 4, p. 1, doi. 10.1007/s00395-013-0365-x

By:

Moberly, Steven;
Mather, Kieren;
Berwick, Zachary;
Owen, Meredith;
Goodwill, Adam;
Casalini, Eli;
Hutchins, Gary;
Green, Mark;
Ng, Yen;
Considine, Robert;
Perry, Kevin;
Chisholm, Robin;
Tune, Johnathan

Publication type:

Article

Evaluation of Serum Glucagon-Like Peptide 1 and Vitamin D Levels in Elderly Patients with Bone Fractures.

Published in:

2020

By:

Pazarci, Özhan;
Dogan, Halef Okan;
Kilinc, Seyran;
Çamurcu, Yalkin;
Dogan, Halef Okan

Publication type:

journal article

Molecular Pharmacology of the Incretin Receptors.

Published in:

2016

By:

Al-Sabah, Suleiman

Publication type:

journal article

Effect of Different Types of Hypoglycemic Medications on Psoriasis: An Analysis of Current Evidence.

Published in:

Dermatology (10188665), 2023, v. 239, n. 2, p. 299, doi. 10.1159/000528026

By:

Sun, Xiaoying;
Cai, Xiaoce;
Liu, Liu;
Li, Hongjin;
Zhou, Yaqiong;
Luo, Ying;
Su, Yonghua;
Li, Bin;
Li, Xin

Publication type:

Article

Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Semaglutide 7.2 mg Achieves Weight Reduction of 21% in Late-Stage STEP UP Trial.

Published in:

Patient Care (Online), 2025, p. 1

By:

Halsey, Grace

Publication type:

Article

Viking Therapeutics Launches Phase 2 Trial for Oral VK2735 in Patients with Obesity.

Published in:

Patient Care (Online), 2025, p. 3

By:

Jennings, Sydney

Publication type:

Article

Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Antiobesity Medications May Help Lower Alcohol Use, New Study Suggests.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management.

Published in:

Patient Care (Online), 2024, p. 3

By:

Jennings, Sydney

Publication type:

Article

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program: Results from the VENTURE phase 2 trial and a phase I oral formulation study found that VK2735, a dual GLP-1 and GIP receptor agonist, demonstrated promise in treating obesity

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D.

Published in:

Patient Care (Online), 2024, p. 4

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs, SGLT-2 Inhibitors Tied to Lower Adverse Cardiovascular and Liver Events in Persons with T2D, MASLD.

Published in:

Patient Care (Online), 2024, p. 3

By:

Jennings, Sydney

Publication type:

Article

New Online Tracker May Help Patients Find GLP-1RA Medication More Easily.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Semaglutide Explored for Treatment of Alcohol, Nicotine Use Disorders.

Published in:

Patient Care (Online), 2024, p. 1

By:

O'Brien, Erin

Publication type:

Article

Real-World Studies Show Significant HbA1c Reductions with GLP-1 RA and Freestyle Libre CGM Used Together.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Viking Therapeutics Dual GIP/GLP-1 Mimetic Drives Weight Loss of Up to 14.7% in Phase 2 Findings.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.

Published in:

Journal of Menopausal Medicine, 2020, v. 26, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93

By:

Hye Min Lee;
Bo Sun Joo;
Chang Hoon Lee;
Heung Yeol Kim;
Ji Hoon Ock;
Young Seok Lee

Publication type:

Article

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.

Published in:

Journal of Menopausal Medicine, 2015, v. 21, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93

By:

Hye Min Lee;
Bo Sun Joo;
Chang Hoon Lee;
Heung Yeol Kim;
Ji Hoon Ock;
Young Seok Lee

Publication type:

Article

Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease.

Published in:

Advanced Biology, 2024, v. 8, n. 3, p. 1, doi. 10.1002/adbi.202300496

By:

Bayne, Sarah;
LeFevre, James;
Olstinske, Kayla;
Ravindran, Sreenithya;
Munusamy, Shankar

Publication type:

Article

Evaluation of Glucagon-Like Peptide 1 (GLP-1) Levels and Oxidative Stress in Preterm Infants.

Published in:

Caspian Journal of Pediatrics, 2022, v. 24, n. 1, p. 18, doi. 10.22088/jbums.24.1.18

By:

Abbasi, E.;
Pishbin, F.;
Shahsavar, N. Tahmasebpour;
Shahabi, R.;
Ghafari, M. E.;
Tabatabai, S.;
Heidari, S.

Publication type:

Article

Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study.

Published in:

Sakarya Tıp Dergisi, 2023, v. 13, n. 1, p. 48, doi. 10.31832/smj.1021311

By:

Vural, Ismail Mert;
Sis, Cagil Onal;
Ulusoy, Kemal Gokhan;
Yildiz, Oguzhan

Publication type:

Article

An LC-MS/MS Method for the Simultaneous Quantification of Insulin, Cortisol, Glucagon-like Peptide 1, Ghrelin, and Osteocalcin.

Published in:

Separations (2297-8739), 2024, v. 11, n. 2, p. 41, doi. 10.3390/separations11020041

By:

Zhang, Zhichao;
Siddiqi, Hareem;
Huang, Yu-Ping;
McClorry, Shannon;
Ji, Peng;
Barile, Daniela;
Slupsky, Carolyn M.

Publication type:

Article

Acetyl-CoA-carboxylase 1 (ACC1) plays a critical role in glucagon secretion.

Published in:

Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03170-w

By:

Veprik, Anna;
Denwood, Geoffrey;
Liu, Dong;
Bany Bakar, Rula;
Morfin, Valentin;
McHugh, Kara;
Tebeka, Nchimunya N.;
Vetterli, Laurène;
Yonova-Doing, Ekaterina;
Gribble, Fiona;
Reimann, Frank;
Hoehn, Kyle L.;
Hemsley, Piers A.;
Ahnfelt-Rønne, Jonas;
Rorsman, Patrik;
Zhang, Quan;
de Wet, Heidi;
Cantley, James

Publication type:

Article

Quassia amara bioactive compounds as a Novel DPP-IV inhibitor: an in-silico study.

Published in:

Bulletin of the National Research Centre, 2022, v. 46, n. 1, p. 1, doi. 10.1186/s42269-022-00890-1

By:

Olugbogi, Ezekiel A.;
Bodun, Damilola S.;
Omoseeye, Shola D.;
Onoriode, Anita O.;
Oluwamoroti, Favour O.;
Adedara, Joshua F.;
Oriyomi, Isaac A.;
Bello, Fatimat O.;
Olowoyeye, Favour O.;
Laoye, Oluwatomilola G.;
Adebowale, Damilola B.;
Adebisi, Aanuoluwapo D.;
Omotuyi, Olaposi I.

Publication type:

Article

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice.

Published in:

JAMA Network Open, 2024, v. 7, n. 9, p. e2433326, doi. 10.1001/jamanetworkopen.2024.33326

By:

Gasoyan, Hamlet;
Pfoh, Elizabeth R.;
Schulte, Rebecca;
Le, Phuc;
Butsch, W. Scott;
Rothberg, Michael B.

Publication type:

Article

Estimated Sustainable Cost-Based Prices for Diabetes Medicines.

Published in:

JAMA Network Open, 2024, v. 7, n. 3, p. e243474, doi. 10.1001/jamanetworkopen.2024.3474

By:

Barber, Melissa J.;
Gotham, Dzintars;
Bygrave, Helen;
Cepuch, Christa

Publication type:

Article

Letter to Editor From Ishaq MU et al: "Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease".

Published in:

Journal of the Endocrine Society, 2025, v. 9, n. 1, p. 1, doi. 10.1210/jendso/bvae217

By:

Ishaq, Muhammad Umer;
Fatima, Noor;
Sharif, Rida;
Awais, Warda

Publication type:

Article

Weight Loss Effect of GLP-1 RAs With Endoscopic Bariatric Therapy and Bariatric Surgeries.

Published in:

Journal of the Endocrine Society, 2023, v. 7, n. 12, p. 1, doi. 10.1210/jendso/bvad129

By:

Imam, Ahmad;
Alim, Hussam;
Binhussein, Mohammad;
Kabli, Abdulrahman;
Alhasnani, Husam;
Allehyani, Abdullah;
Aljohani, Ammar;
Mohorjy, Ahmad;
Tawakul, Abdullah;
Samannodi, Mohammed;
Taha, Wael

Publication type:

Article

Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women.

Published in:

Journal of the Endocrine Society, 2022, v. 6, n. 9, p. 1, doi. 10.1210/jendso/bvac111

By:

Åkerström, Thorbjörn;
Stolpe, Malene N;
Widmer, Renate;
Dejgaard, Thomas F;
Højberg, Jens M;
Møller, Kirsten;
Hansen, Jakob S;
Trinh, Beckey;
Holst, Jens J;
Thomsen, Carsten;
Pedersen, Bente K;
Ellingsgaard, Helga

Publication type:

Article

The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors.

Published in:

Journal of the Endocrine Society, 2020, v. 4, n. 2, p. N.PAG, doi. 10.1210/jendso/bvz036

By:

Ahrén, Bo;
Yamada, Yuichiro;
Seino, Yutaka

Publication type:

Article

In silico ADME and target prediction studies of Alogliptin as drug molecule.

Published in:

Drug Metabolism Reviews, 2025, v. 57, n. 1, p. 1, doi. 10.1080/03602532.2024.2439102

By:

Patil, Vaishnavi Sanjay;
Seth, Bhavika Kapil;
Chaudhari, Hemchandra K.

Publication type:

Article

156. IN VITRO EVALUATION OF HUMAN DRUG METABOLIZING ENZYMES USING AUTOMATED, HIGHLY SENSITIVE, GLP COMPLIANT METHODS.

Published in:: 2002
Publication type:: Abstract

Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review.

Published in:

Visceral Medicine, 2022, v. 38, n. 2, p. 126, doi. 10.1159/000519611

By:

Roeb, Elke

Publication type:

Article